AAAAAA

   
Results: 1-25 | 26-45
Results: 1-25/45
Digestive and liver disease - Another step forward
Authors: Porro, GB
Citation: Gb. Porro, Digestive and liver disease - Another step forward, DIG LIVER D, 33(1), 2001, pp. 1-1
"Cervia Working Group Report": Guidelines on the diagnosis and treatment of Helicobacter pylori infection
Authors: Caselli, M Parente, F Palli, D Covacci, A Alvisi, V Gasbarrini, G Porro, GB
Citation: M. Caselli et al., "Cervia Working Group Report": Guidelines on the diagnosis and treatment of Helicobacter pylori infection, DIG LIVER D, 33(1), 2001, pp. 75-80
The C-13-urea breath test for non-invasive diagnosis of Helicobacter pylori infection: which procedure and which measuring equipment?
Authors: Parente, F Porro, GB
Citation: F. Parente et Gb. Porro, The C-13-urea breath test for non-invasive diagnosis of Helicobacter pylori infection: which procedure and which measuring equipment?, EUR J GASTR, 13(7), 2001, pp. 803-806
The effects on gastroduodenal mucosa of a new nonsteroidal anti-inflammatory drug, amtolmetin-guacyl, versus piroxicam in healthy volunteers: a short-term, double-blind, endoscopically controlled study
Authors: Lazzaroni, M Anderloni, A Porro, GB
Citation: M. Lazzaroni et al., The effects on gastroduodenal mucosa of a new nonsteroidal anti-inflammatory drug, amtolmetin-guacyl, versus piroxicam in healthy volunteers: a short-term, double-blind, endoscopically controlled study, EUR J GASTR, 13(7), 2001, pp. 833-839
Review article: Helicobacter pylori and NSAID gastropathy
Authors: Lazzaroni, M Porro, GB
Citation: M. Lazzaroni et Gb. Porro, Review article: Helicobacter pylori and NSAID gastropathy, ALIM PHARM, 15, 2001, pp. 22-27
Presence of gastric autoantibodies impairs gastric secretory function in patients with Helicobacter pylori-positive duodenal ulcer
Authors: Parente, F Negrini, R Imbesi, V Maconi, G Sainaghi, M Vago, L Porro, GB
Citation: F. Parente et al., Presence of gastric autoantibodies impairs gastric secretory function in patients with Helicobacter pylori-positive duodenal ulcer, SC J GASTR, 36(5), 2001, pp. 474-478
Gastric apoptosis and Helicobacter pylori infection: an intricate matter
Authors: Parente, F Caselli, M Porro, GB
Citation: F. Parente et al., Gastric apoptosis and Helicobacter pylori infection: an intricate matter, SC J GASTR, 36(2), 2001, pp. 113-115
Preparation, premedication, and surveillance
Authors: Lazzaroni, M Porro, GB
Citation: M. Lazzaroni et Gb. Porro, Preparation, premedication, and surveillance, ENDOSCOPY, 33(2), 2001, pp. 103-108
Preoperative characteristics and postoperative behavior of rowel wall on risk of recurrence after conservative surgery in Crohn's disease - A prospective study
Authors: Maconi, G Sampietro, GM Cristaldi, M Danelli, P Russo, A Porro, GB Taschieri, AM
Citation: G. Maconi et al., Preoperative characteristics and postoperative behavior of rowel wall on risk of recurrence after conservative surgery in Crohn's disease - A prospective study, ANN SURG, 233(3), 2001, pp. 345-352
Do some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy?
Authors: Maconi, G Parente, F Russo, A Vago, L Imbesi, V Porro, GB
Citation: G. Maconi et al., Do some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy?, AM J GASTRO, 96(2), 2001, pp. 359-366
Prolonging proton pump inhibitor-based anti-Helicobacter pylori treatment from one to two weeks in duodenal ulcer: is it worthwhile?
Authors: Maconi, G Russo, A Imbesi, V Cucino, C Porro, GB
Citation: G. Maconi et al., Prolonging proton pump inhibitor-based anti-Helicobacter pylori treatment from one to two weeks in duodenal ulcer: is it worthwhile?, DIG LIVER D, 32(4), 2000, pp. 275-280
Efficacy of pantoprazole in the prevention of peptic ulcers, induced by non-steroidal anti-inflammatory drugs: a prospective, placebo-controlled, double-blind, parallel-group study
Authors: Porro, GB Lazzaroni, M Imbesi, V Montrone, F Santagada, T
Citation: Gb. Porro et al., Efficacy of pantoprazole in the prevention of peptic ulcers, induced by non-steroidal anti-inflammatory drugs: a prospective, placebo-controlled, double-blind, parallel-group study, DIG LIVER D, 32(3), 2000, pp. 201-208
Gastro-oesophageal reflux and Helicobacter pylori
Authors: Pace, F Porro, GB
Citation: F. Pace et Gb. Porro, Gastro-oesophageal reflux and Helicobacter pylori, DIG LIVER D, 32, 2000, pp. S202-S206
Farewell to the Italian Journal of Gastroenterology and Hepatology. Welcome to Digestive and Liver Disease!
Authors: Porro, GB Bonino, F
Citation: Gb. Porro et F. Bonino, Farewell to the Italian Journal of Gastroenterology and Hepatology. Welcome to Digestive and Liver Disease!, DIG LIVER D, 32(1), 2000, pp. 1-2
Prevalence and clinical features of heterotopic gastric mucosa in the upper oesophagus (inlet patch)
Authors: Maconi, G Pace, F Vago, L Carsana, L Bargiggia, S Porro, GB
Citation: G. Maconi et al., Prevalence and clinical features of heterotopic gastric mucosa in the upper oesophagus (inlet patch), EUR J GASTR, 12(7), 2000, pp. 745-749
Should we eradicate Helicobacter pylori in patients with recurrent gastro-oesophageal reflux disease?
Authors: Porro, GB Pace, F
Citation: Gb. Porro et F. Pace, Should we eradicate Helicobacter pylori in patients with recurrent gastro-oesophageal reflux disease?, EUR J GASTR, 12, 2000, pp. S7-S10
Helicobacter pylori seropositivity, lipid concentrations and haemostatic factors - Reply
Authors: Parente, F Porro, GB
Citation: F. Parente et Gb. Porro, Helicobacter pylori seropositivity, lipid concentrations and haemostatic factors - Reply, J INTERN M, 248(4), 2000, pp. 355-356
Helicobacter pylori CagA seropositivity does not influence inflammatory parameters, lipid concentrations and haemostatic factors in healthy individuals
Authors: Parente, F Imbesi, V Cucino, C Maconi, G Russo, U Duca, PG Porro, GB
Citation: F. Parente et al., Helicobacter pylori CagA seropositivity does not influence inflammatory parameters, lipid concentrations and haemostatic factors in healthy individuals, J INTERN M, 247(2), 2000, pp. 213-217
Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis
Authors: Ardizzone, S Bollani, S Bettica, P Bevilacqua, M Molteni, P Porro, GB
Citation: S. Ardizzone et al., Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis, J INTERN M, 247(1), 2000, pp. 63-70
Trends, controversies and contradictions in the management of gastroesophageal reflux disease patients
Authors: Pace, F Porro, GB
Citation: F. Pace et Gb. Porro, Trends, controversies and contradictions in the management of gastroesophageal reflux disease patients, SC J GASTR, 35(12), 2000, pp. 1233-1237
Long-term results and multivariate analysis of prognostic factors in 138 consecutive patients operated on for Crohn's disease using "bowel-sparing" techniques
Authors: Cristaldi, M Sampietro, GM Danelli, P Bollani, S Porro, GB Taschieri, AM
Citation: M. Cristaldi et al., Long-term results and multivariate analysis of prognostic factors in 138 consecutive patients operated on for Crohn's disease using "bowel-sparing" techniques, AM J SURG, 179(4), 2000, pp. 266-270
Focal gastric inflammatory infiltrates in inflammatory bowel diseases: Prevalence, immunohistochemical characteristics, and diagnostic role
Authors: Parente, F Cucino, C Bollani, S Imbesi, V Maconi, G Bonetto, S Vago, L Porro, GB
Citation: F. Parente et al., Focal gastric inflammatory infiltrates in inflammatory bowel diseases: Prevalence, immunohistochemical characteristics, and diagnostic role, AM J GASTRO, 95(3), 2000, pp. 705-711
Cost effectiveness of omeprazole and ranitidine in intermittent treatment of symptomatic gastro-oesophageal reflux disease
Authors: Stalhammar, NO Carlsson, J Peacock, R Muller-Lissner, S Bigard, MA Porro, GB Ponce, J Hosie, J Scott, M Weir, DG Fulton, C Gillon, K Bardhan, KD
Citation: No. Stalhammar et al., Cost effectiveness of omeprazole and ranitidine in intermittent treatment of symptomatic gastro-oesophageal reflux disease, PHARMACOECO, 16(5), 1999, pp. 483-497
Mesalazine foam (Salofalk (R) foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk (R) enema
Authors: Ardizzone, S Doldo, P Ranzi, T Sturniolo, GC Giglio, LA Annese, V D'Arienzo, A Gaia, E Gullini, S Riegler, G Valentini, M Massa, P Del Piano, M Rossini, F Guidetti, CS Pera, A Greinwald, R Porro, GB
Citation: S. Ardizzone et al., Mesalazine foam (Salofalk (R) foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk (R) enema, ITAL J GAST, 31(8), 1999, pp. 677-684
Clinical and gastroscopic evaluation of amtolmetin guacyl versus diclofenac in patients with rheumatoid arthritis
Authors: Porro, GB Montrone, F Lazzaroni, M Manzionna, G Caruso, I
Citation: Gb. Porro et al., Clinical and gastroscopic evaluation of amtolmetin guacyl versus diclofenac in patients with rheumatoid arthritis, ITAL J GAST, 31(5), 1999, pp. 378-385
Risultati: 1-25 | 26-45